Publications (9) Idoia Bilbao Del Olmo publications

2024

  1. Accidental intravenous probiotic injection in an immunocompromised patient: Implications and consequences

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

    Journal of Physiology and Biochemistry

  3. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

    Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190

2022

  1. Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

    Cancer Imaging, Vol. 22, Núm. 1

2021

  1. Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study

    European Journal of Internal Medicine, Vol. 91, pp. 3-9

  2. Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage

    Hepatology, Vol. 74, Núm. 5, pp. 2791-2807

2019

  1. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk

    Nutrients, Vol. 11, Núm. 11

2018

  1. Pneumatocele during sorafenib therapy: First report of an unusual complication

    Oncotarget, Vol. 9, Núm. 5, pp. 6652-6656

2015

  1. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: Analysis of the European multicentre trial SORAMIC

    Liver International, Vol. 35, Núm. 2, pp. 620-626